Restore American Innovation with PERA
Restore American Innovation with PERA
The Patent Eligibility Restoration Act (PERA) is a bold, bipartisan fix for America’s broken patent system.
- Outdated court rulings have blocked innovation in diagnostics, personalized medicine, software, and AI — while global competitors surge ahead.
- PERA restores clarity, levels the playing field, and ensures U.S. inventors can protect their breakthroughs.
Support PERA today and help secure America’s leadership in innovation.
PERA restores patent protection for real medical and biotech innovations while keeping strict limits in place. It does not allow patents on genes, natural phenomena, or basic science — but it ensures new tests, treatments, and life-saving technologies can be protected in the United States.
PERA reestablishes patent eligibility for true software, AI, and tech inventions, giving U.S. innovators the same protections as their global rivals. It does not allow patents on abstract ideas, mental steps, or math formulas — but it provides the certainty developers and startups need to invest, grow, and compete.
For decades, court-made “exceptions” have distorted U.S. patent law, blocking protection for critical technologies. PERA resets the rules — removing these ad hoc exclusions while still barring patents on unmodified genes, natural phenomena, and abstract processes. The result: restored certainty, stronger investment, and more American innovation and jobs.
Restore American Innovation with PERA
The Patent Eligibility Restoration Act (PERA) is a bold, bipartisan fix for America’s broken patent system. Outdated court rulings have blocked innovation in diagnostics, personalized medicine, software, and AI — while global competitors surge ahead. PERA restores clarity, levels the playing field, and ensures U.S. inventors can protect their breakthroughs.
Support PERA today and help secure America’s leadership in innovation.
PERA restores patent protection for real medical and biotech innovations while keeping strict limits in place. It does not allow patents on genes, natural phenomena, or basic science — but it ensures new tests, treatments, and life-saving technologies can be protected in the United States.
PERA reestablishes patent eligibility for true software, AI, and tech inventions, giving U.S. innovators the same protections as their global rivals. It does not allow patents on abstract ideas, mental steps, or math formulas — but it provides the certainty developers and startups need to invest, grow, and compete.
For decades, court-made “exceptions” have distorted U.S. patent law, blocking protection for critical technologies. PERA resets the rules — removing these ad hoc exclusions while still barring patents on unmodified genes, natural phenomena, and abstract processes. The result: restored certainty, stronger investment, and more American innovation and jobs.